The Janssen COVID-19 Vaccine- What Pharmacists Need to Know | Locked On Pharmacy

Published: March 4, 2021, 5:01 a.m.

The Janssen COVID-19 Vaccine: What Pharmacists Need to Know On February 27, the FDA authorized the emergency use of a COVID-19 vaccine developed by the Johnson & Johnson subsidiary, Janssen Biotech – the third such vaccine to be so authorized. What do pharmacists need to know about this product? Our guests are Michael Hogue, President of APhA and a member of the CDC working group on COVID vaccines, and Stephan Foster, APhA’s liaison to the CDC’s Advisory Committee on Immunization Practices. See omnystudio.com/listener for privacy information.